Purevax RCPCh FeLV

Unknown🇪🇺 European Union

EMA Page

Authorised Date: N/A
Approval ID: 93156a367793c824
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

Up\-to\-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website](https://medicines.health.europa.eu/veterinary/en/search-medicines?keys=%22Purevax%20RCPCh%20FelV%22)

Therapeutic & Classification

Therapeutic Indication

N/A

Therapeutic Area (MeSH)

N/A

ATC Code

N/A

ATC Item

N/A

Pharmacotherapeutic Group

Immunologicals for felidae

Active Substances

Active Substance (Summary)

attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)

inactivated feline calicivirosis antigens (FCV 431 and G1 strains)

attenuated feline panleucopenia virus (PLI IV)

FeLV recombinant canarypox virus (vCP97)

attenuated Chlamydophila felis (905 strain)

INN / Common Names

vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections

Active Substance Details

Active substance details are not yet available.

Quick Info

Approval ID93156a367793c824

Product NumberN/A

StatusAuthorised

Authorised DateN/A

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Purevax RCPCh FeLV

Medicine Name

Purevax RCPCh FeLV

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals